Navigation Links
EU Adopts New Diagnostics and Medical Device Regulations, USDM Life Sciences Helps Organizations Comply
Date:4/8/2017

USDM Life Sciences, the leading risk management, technological innovation and business process optimization firm for the life sciences and healthcare industries, is already working with medical device manufacturers to comply with the two new European Union medical device regulations.

On April 5, 2017, the In vitro Diagnostic Medical Devices Regulation (IVDR) and Medical Devices Regulation (MDR) were approved by the European Parliament.

USDM has been actively following these regulations and is already working with their medical device clients to help plan their regulatory understanding, strategy and implementation. Jay Crowley and Grant Hodgkins oversee medical device compliance services and solutions for USDM.

Crowley is the author of the US FDA UDI Final Rule and is Vice President of UDI Services and Solutions at USDM. Hodgkins was a senior manager at Novartis and Alcon for Master Data Management (MDM) and Product Identification and is the Vice President of Commercial Services and Solutions at USDM.

“These directives are the most recent steps in the global rollout of new medical device identification regulations. These steps, along with the US FDA UDI Final Rule and other similar regulations from other countries that are expected soon will continue the worldwide initiative to improve medical device identification, product quality and patient safety,” said Crowley. “We look forward to helping the industry with this important initiative.”

For medical device manufacturers selling devices in the EU, the timeline for compliance has begun – three years for MDR and 5 years for IVDR. USDM will continue to support Medical Device companies through its Knowledge Webinars, White Papers and participation in the European UDI Conference in Brussels May 16-18. and the US UDI Conference in Baltimore June 7-8. USDM is also presenting a webinar, New EU Diagnostics and Medical Device Regulations on April 20th.

About USDM Life Sciences
USDM Life Sciences is a global life science and healthcare services company, providing strategy and compliant technology solutions to regulated industries. If you work in Life Sciences or Healthcare, partnering with USDM Life Sciences makes it easy to accelerate innovation and maximize productivity. USDM Life Sciences only focuses on regulated industries and has built trusted partnerships with the most innovative technology companies in the world, and boast a staff of industry leading experts in the areas of technology and compliance.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14223667.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Vitatech Adopts Cinnamon through the American Botanical Councils Adopt-an-Herb Program
2. Multivitamin Direct Adopts InstantGMP-Lite as Their Electronic Batch Record Software
3. Oklahoma State Medicaid Adopts Drug Price Benchmark, PAC
4. InspireMD Secures Financing to Accelerate Advancements in Product Development and Adopts a One Year Stockholder Rights Plan
5. Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support
6. Ixoreal Biomed "Adopts" Ashwagandha through the American Botanical Council
7. FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R
8. Neogen CEO adopts 10b5-1 Trading Plan
9. Kineticos Adopts Practice Area Structure, Expands Consulting Service Areas
10. Texas Fertility Center Adopts Next-gen DNA Sequencing, Inclusive Screening at all of Its San Antonio and Austin Fertility Clinics
11. Teawolf "Adopts" Guayusa under Agreement with American Botanical Council
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2019)... ... 03, 2019 , ... Yesterday, at the 2019 meeting of Outsourcing in Clinical ... L. Sherley, M.D., Ph.D., discussed important design factors that currently limit the success of ... and suppliers of clinical trials, in his talk Dr. Sherley focused on ...
(Date:9/24/2019)... ... 24, 2019 , ... Personalized Stem Cells, Inc ... for clinical trial sites and physician investigators. The clinical trial sites are ... , Clinical trial sites are currently located in San Diego and Los Angeles ...
(Date:9/17/2019)... POWAY, Calif. (PRWEB) , ... September 17, 2019 , ... ... of osteoarthritis. At only four months old, Tucker was limping and lame on his ... hip and elbow dysplasia and it was called “the worst case the vet had ...
(Date:9/17/2019)... , ... September 16, 2019 , ... ... co-located with the China Focus @ Biotech Week Boston, a forum organized by ... collaborations in healthcare innovation. , After a careful process of evaluation, twelve companies ...
Breaking Biology Technology:
(Date:9/22/2019)... ... 2019 , ... A new report from Strategic Directions International ... products. The report, Lab Instrumentation Markets for Pharmaceuticals, Biopharmaceuticals, & CROs , ... the largest source of demand for laboratory instrumentation. , With the rise ...
(Date:9/17/2019)... ... September 17, 2019 , ... Last week, Blackrock ... engineers from the Medical University of Warsaw, met at the Presidential Palace of ... creating a neuroprosthetic system as part of an initiative called "Startups in the ...
(Date:9/14/2019)... ... September 12, 2019 , ... Catalent, the leading global provider ... and consumer health products, today announced that professor David Schaffer has been appointed ... an integral advisory role on the gene therapy industry, as Catalent has moved ...
Breaking Biology News(10 mins):